Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
100.49
+6.69 (7.13%)
At close: Dec 5, 2025, 4:00 PM EST
102.49
+2.00 (1.99%)
After-hours: Dec 5, 2025, 5:49 PM EST
Palvella Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 13.4 | 5.94 | 3.08 | 4.16 |
| Research & Development | 18.26 | 8.15 | 8.79 | 13.88 |
| Operating Expenses | 31.66 | 14.1 | 11.87 | 18.04 |
| Operating Income | -31.66 | -14.1 | -11.87 | -18.04 |
| Interest Expense | -5.38 | -4.32 | - | -10.36 |
| Interest & Investment Income | 1.71 | - | 6.27 | - |
| Other Non Operating Income (Expenses) | 0.72 | -0.12 | 1.2 | -0.17 |
| EBT Excluding Unusual Items | -34.62 | -18.53 | -4.41 | -28.58 |
| Other Unusual Items | 1.67 | 1.1 | 23.1 | - |
| Pretax Income | -32.95 | -17.43 | 18.69 | -28.58 |
| Income Tax Expense | - | - | - | -1.03 |
| Net Income | -32.95 | -17.43 | 18.69 | -27.55 |
| Preferred Dividends & Other Adjustments | -0.58 | - | 14.81 | - |
| Net Income to Common | -32.37 | -17.43 | 3.88 | -27.55 |
| Shares Outstanding (Basic) | 9 | 2 | 2 | 6 |
| Shares Outstanding (Diluted) | 9 | 2 | 2 | 6 |
| Shares Change (YoY) | 60.51% | 24.08% | -68.63% | - |
| EPS (Basic) | -3.53 | -7.83 | 2.19 | -4.82 |
| EPS (Diluted) | -3.53 | -7.83 | 2.17 | -4.82 |
| EBIT | -31.66 | -14.1 | -11.87 | -18.04 |
Source: S&P Capital IQ. Standard template.
Financial Sources.